{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:38:47Z","timestamp":1790199527486,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["HL144552"],"award-info":[{"award-number":["HL144552"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["HL164016-01A1"],"award-info":[{"award-number":["HL164016-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["HL157975-01A1"],"award-info":[{"award-number":["HL157975-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011324","name":"Qingdao University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jtha.2024.02.003","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:23:14Z","timestamp":1707870194000},"page":"1358-1365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpura"],"prefix":"10.1016","volume":"22","author":[{"given":"X. Long","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.02.003_bib1","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.02.003_bib2","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1538-7836.2006.02164.x","article-title":"Multiple B-cell clones producing antibodies directed to the spacer and disintegrin\/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura","volume":"4","author":"Luken","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.003_bib3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","article-title":"Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura","volume":"95","author":"Zheng","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.02.003_bib4","doi-asserted-by":"crossref","first-page":"9620","DOI":"10.1073\/pnas.1512561112","article-title":"High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome","volume":"112","author":"Casina","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.02.003_bib5","doi-asserted-by":"crossref","first-page":"30136","DOI":"10.1074\/jbc.M305331200","article-title":"Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13","volume":"278","author":"Zheng","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.02.003_bib6","doi-asserted-by":"crossref","first-page":"29428","DOI":"10.1074\/jbc.M505513200","article-title":"The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor","volume":"280","author":"Ai","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.02.003_bib7","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1161\/ATVBAHA.111.229609","article-title":"Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis","volume":"31","author":"Xiao","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.02.003_bib8","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2009-07-235101","article-title":"Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor","volume":"115","author":"Jin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.02.003_bib9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2008-04-148759","article-title":"Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity","volume":"112","author":"Gao","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.02.003_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH06-03-0135","article-title":"Amino acid regions 572\u2013579 and 657\u2013666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP","volume":"96","author":"Luken","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.003_bib11","first-page":"2993","article-title":"Mechanisms of inhibition of human monoclonal antibodies in immune thrombotic thrombocytopenic purpura","volume":"141","author":"Halkidis","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.02.003_bib12","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jtha.2023.02.011","article-title":"Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura","volume":"21","author":"Underwood","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.003_bib13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.003_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3324\/haematol.2018.198275","article-title":"Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"104","author":"Staley","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.02.003_bib15","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/bloodadvances.2019000939","article-title":"Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura","volume":"3","author":"Sui","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.02.003_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.02.003_bib17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.5858\/arpa.2022-0050-RA","article-title":"ADAMTS13 biomarkers in management of immune thrombotic thrombocytopenic purpura","volume":"147","author":"Sui","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtha.2024.02.003_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ab.2013.07.022","article-title":"Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system","volume":"442","author":"Chen","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jtha.2024.02.003_bib19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1160\/TH11-05-0337","article-title":"Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura","volume":"106","author":"Li","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.003_bib20","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1111\/jth.15297","article-title":"Determination of anti-ADAMTS-13 autoantibody titers in ELISA: influence of ADAMTS-13 presentation and autoantibody detection","volume":"19","author":"Dekimpe","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.003_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2016-12-758656","article-title":"Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura","volume":"130","author":"Alwan","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.02.003_bib22","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1538-7836.2006.02025.x","article-title":"Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in\u00a0vivo","volume":"4","author":"Shelat","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.003_bib23","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/trf.13584","article-title":"ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in\u00a0vitro","volume":"56","author":"Ostertag","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2024.02.003_bib24","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","article-title":"Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jtha.2024.02.003_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3324\/haematol.2013.094151","article-title":"Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura","volume":"99","author":"Ferrari","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.02.003_bib26","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/bloodadvances.2019001375","article-title":"Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function","volume":"4","author":"Schelpe","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.02.003_bib27","doi-asserted-by":"crossref","first-page":"18584","DOI":"10.1073\/pnas.1413282112","article-title":"Allosteric activation of ADAMTS13 by von Willebrand factor","volume":"111","author":"Muia","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.02.003_bib28","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/jth.15332","article-title":"A\u00a0human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura","volume":"19","author":"Halkidis","year":"2021","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624000692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624000692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:09:53Z","timestamp":1762549793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1538783624000692"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.02.003","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}